Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis

MLA

Gabriela Gremel, et al. “Metallothionein 1E Is Methylated in Malignant Melanoma and Increases Sensitivity to Cisplatin-Induced Apoptosis.” Melanoma Research, vol. 20, Oct. 2010, pp. 392–400. EBSCOhost, https://doi.org/10.1097/cmr.0b013e32833d32a6.

APA

Gabriela Gremel, William M. Gallagher, Shauna Hegarty, Mario F. Fraga, Manel Esteller, Peter A. Dervan, William J. Faller, Denise Ryan, & Mairin Rafferty. (2010). Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis. Melanoma Research, 20, 392–400. https://doi.org/10.1097/cmr.0b013e32833d32a6

Chicago

Gabriela Gremel, William M. Gallagher, Shauna Hegarty, Mario F. Fraga, Manel Esteller, Peter A. Dervan, William J. Faller, Denise Ryan, and Mairin Rafferty. 2010. “Metallothionein 1E Is Methylated in Malignant Melanoma and Increases Sensitivity to Cisplatin-Induced Apoptosis.” Melanoma Research 20 (October): 392–400. doi:10.1097/cmr.0b013e32833d32a6.